PALVELLA THERAPEUTICS, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

PALVELLA THERAPEUTICS, INC. reported Cash And Cash Equivalents At Carrying Value of $57.98 million for the year ending 2025.

  • PALVELLA THERAPEUTICS, INC. showed a decrease of -30.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from PALVELLA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
  • XBRL data for this metric is available from 2012 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2013: $0.00 | Q2 2013: $5.2 thousand | Q3 2013: $688.00 | Q1 2014: $3.27 million | Q2 2014: $1.49 million | Q3 2014: $936.2 thousand | Q1 2015: $13.17 million | Q2 2015: $10.03 million | Q3 2015: $32.25 million | Q1 2016: $31.19 million | Q2 2016: $40.37 million | Q3 2016: $36.56 million | Q1 2017: $55.24 million | Q2 2017: $50.32 million | Q3 2017: $89.92 million | Q1 2018: $109.52 million | Q2 2018: $50.58 million | Q3 2018: $89.48 million | Q1 2019: $52.09 million | Q2 2019: $54.90 million | Q3 2019: $46.07 million | Q1 2020: $47.43 million | Q2 2020: $44.30 million | Q3 2020: $66.89 million | Q1 2021: $66.84 million | Q2 2021: $119.10 million | Q3 2021: $125.05 million | Q1 2022: $83.74 million | Q2 2022: $54.26 million | Q3 2022: $48.42 million | Q1 2023: $39.74 million | Q2 2023: $44.94 million | Q3 2023: $32.89 million | Q1 2024: $19.08 million | Q2 2024: $19.73 million | Q3 2024: $19.36 million | Q1 2025: $75.63 million | Q2 2025: $70.43 million | Q3 2025: $63.57 million.
  • Over the full 17 years of available data (2012 to 2025), PALVELLA THERAPEUTICS, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 816.4%.
  • Historical annual values: Fiscal year 2025: $57.98 million | Fiscal year 2024: $83.60 million | Fiscal year 2023: $7.35 million | Fiscal year 2022: $38.64 million | Fiscal year 2021: $117.76 million | Fiscal year 2020: $70.44 million | Fiscal year 2019: $62.26 million | Fiscal year 2018: $74.87 million | Fiscal year 2017: $37.88 million | Fiscal year 2016: $29.36 million | Fiscal year 2015: $29.35 million | Fiscal year 2014: $18.47 million | Fiscal year 2014: $11.1 thousand | Fiscal year 2013: $3.69 million | Fiscal year 2013: $5.2 thousand | Fiscal year 2013: $0.00 | Fiscal year 2012: $6.33 million.
  • Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: